Paclitaxel is widely used in the combination chemotherapy for many cancers including esophageal squamous cell carcinoma (ESCC). However, the paclitaxel resistance occurs frequently in treating ESCC and the mechanism is not fully understood yet. The heterogeneity of gene expression within the drug-resistant cancer cells may be one of the major factors contributing to its resistance. In the present study, we successfully induced paclitaxel resistance in ESCC cell line KYSE-30 through low dose and long-term treatment of paclitaxel.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2DY27RH
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Recent updating of the World Health Organization (WHO) classification of central nervous system (CNS) tumors in 2016 demonstrates...
-
In our previous work, the dichloromethane-methanol (1:1 v/v) extract, fractions and isolated compounds from Polyscias fulva stem bark showed...
-
Cincinnati.com No fooling; go get your head (and neck) examined for free Cincinnati.com Thursday, get your head examined. UC Health ...
-
Background Agricultural work can expose workers to increased risk of heat strain and volume depletion due to repeated exposures to high ambi...
-
Nursing students' perceptions of a video-based serious game's educational value: A pilot study. Nurse Educ Today. 2017 Dec 28;...
-
Anaphora is a rhetorical term for the repetition of a word or phrase at the beginning of successive clauses or verses. from #AlexandrosSfa...
-
Abstract We introduce a novel diagnostic Visual Voiding Device (VVD), which has the ability to visually document urinary voiding events an...
-
Method combines radiomics with three - compartment breast image analysis of dual - energy mammography (Source: The Doctors Lounge - Oncology...
-
Cone beam computerized tomography (CBCT) has been widely used in dental implanting. However, the local hospitals usually don’t have access t...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου